Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.8057
-0.0203 (-2.46%)
At close: Sep 28, 2026, 4:00 PM EDT
0.8260
+0.0203 (2.52%)
After-hours: Sep 28, 2026, 7:30 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $153.85 million as of September 28, 2026. Its market cap has increased by 14.33% in one year.
Market Cap
153.85M
Enterprise Value
144.28M
1-Year Change
14.33%
Ranking
Category
Stock Price
$0.81
ChartMarket Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $153.85M, a decrease of -70.08%. That is a compound annual growth rate of -21.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 153.85M | 7.66% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Electromed | 233.25M |
| Profound Medical | 211.11M |
| Neuronetics | 208.78M |
| RxSight | 193.82M |
| Quantum-Si incorporated | 182.61M |
| Quanterix | 154.65M |
| Owlet | 147.28M |
| Nyxoah | 145.98M |